Response
- PMID: 26209711
- PMCID: PMC4836805
- DOI: 10.1093/jnci/djv201
Response
Comment on
-
Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer.J Natl Cancer Inst. 2015 May 9;107(7):djv119. doi: 10.1093/jnci/djv119. Print 2015 Jul. J Natl Cancer Inst. 2015. PMID: 25957435
-
RE: Androgen Deprivation With or Without Radiation Therapy for Clinically Node-Positive Prostate Cancer.J Natl Cancer Inst. 2015 Jul 23;107(9):djv200. doi: 10.1093/jnci/djv200. Print 2015 Sep. J Natl Cancer Inst. 2015. PMID: 26209710 Free PMC article. No abstract available.
References
-
- Briganti A, Blute ML, Eastham JH, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol. 2009;55 (6):1251–1265. - PubMed
-
- Abdollah F, Karnes RJ, Suardi N, et al. Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer. J Clin Oncol. 2014;32 (35):3939–3947. - PubMed
-
- Briganti A, Karnes JR, Da Pozzo LF, et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol. 2009;55 (2):261–270. - PubMed
-
- Daneshmand S, Quek ML, Stein JP, et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol. 2004;172(6 Pt 1):2252–2255. - PubMed
-
- Rusthoven CG, Carlson JA, Waxweiler TV, et al. The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study. Int J Radiat Oncol Biol Phys. 2014;88 (5):1064–1073. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical